US FDA warns public of fraudulent stem cell schemes
This article was originally published in Clinica
Executive Summary
US regulators have warned consumers about fraudsters peddling potentially dangerous and ineffective stem cell treatments. They noted that only one stem cell product is approved by the US FDA – Hemacord, a haematopoietic progenitor cell product derived from cord blood, which is manufactured by the New York Blood Center and used for specified indications in patients with disorders affecting the body’s blood-forming system.
You may also be interested in...
Moderna's Valera Takes mRNA Approach To Combat Zika
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan's Price Reform Pledge: Will Others Follow?
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Clinton's Drug Price Plan: Threat Or Flash In The Political Pan?
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.